Vitamin D and Autism Spectrum Disorder: A Literature Review

被引:76
作者
Mazahery, Hajar [1 ]
Camargo, Carlos A., Jr. [2 ]
Conlon, Cathryn [1 ]
Beck, Kathryn L. [1 ]
Kruger, Marlena C. [1 ]
von Hurst, Pamela R. [1 ]
机构
[1] Massey Univ, Inst Food Sci & Technol, Sch Food & Nutr, Palmerston North 4474, New Zealand
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA 02114 USA
关键词
review; Autism Spectrum Disorder; ASD; Vitamin D; 25(OH)D; intervention; latitude; ethnicity; migration; season; birth; conception; PERVASIVE DEVELOPMENTAL DISORDERS; NERVE GROWTH-FACTOR; PERINATAL RISK-FACTORS; INCREASED SERUM-LEVELS; DSM-IV-TR; D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; OXIDATIVE STRESS; NEURODEVELOPMENTAL DISORDERS; MITOCHONDRIAL DYSFUNCTION;
D O I
10.3390/nu8040236
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Low vitamin D status in early development has been hypothesised as an environmental risk factor for Autism Spectrum Disorder (ASD), given the concurrent increase in the prevalence of these two conditions, and the association of vitamin D with many ASD-associated medical conditions. Identification of vitamin D-ASD factors may provide indications for primary and secondary prevention interventions. We systematically reviewed the literature for studies on vitamin D-ASD relationship, including potential mechanistic pathways. We identified seven specific areas, including: latitude, season of conception/birth, maternal migration/ethnicity, vitamin D status of mothers and ASD patients, and vitamin D intervention to prevent and treat ASD. Due to differences in the methodological procedures and inconsistent results, drawing conclusions from the first three areas is difficult. Using a more direct measure of vitamin D status-that is, serum 25(OH) D level during pregnancy or childhood-we found growing evidence for a relationship between vitamin D and ASD. These findings are supported by convincing evidence from experimental studies investigating the mechanistic pathways. However, with few primary and secondary prevention intervention trials, this relationship cannot be determined, unless randomised placebo-controlled trials of vitamin D as a preventive or disease-modifying measure in ASD patients are available.
引用
收藏
页数:35
相关论文
共 203 条
[1]   Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity [J].
Adams, James B. ;
Audhya, Tapan ;
McDonough-Means, Sharon ;
Rubin, Robert A. ;
Quig, David ;
Geis, Elizabeth ;
Gehn, Eva ;
Loresto, Melissa ;
Mitchell, Jessica ;
Atwood, Sharon ;
Barnhouse, Suzanne ;
Lee, Wondra .
NUTRITION & METABOLISM, 2011, 8
[2]   Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates [J].
Al Anouti, Fatme ;
Thomas, Justin ;
Abdel-Wareth, Laila ;
Rajah, Jaishen ;
Grant, William B. ;
Haq, Afrozul .
DERMATO-ENDOCRINOLOGY, 2011, 3 (04) :235-239
[3]   A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders [J].
Alabdali, Altaf ;
Al-Ayadhi, Laila ;
El-Ansary, Afaf .
BEHAVIORAL AND BRAIN FUNCTIONS, 2014, 10
[4]   Protective and restorative potency of Vitamin D on persistent biochemical autistic features induced in propionic acid-intoxicated rat pups [J].
Alfawaz, Hanan A. ;
Bhat, Ramesa Shafi ;
Al-Ayadhi, Laila ;
El-Ansary, Afaf K. .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14 :416
[5]   1α,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human Monocytes [J].
Almerighi, Cristiana ;
Sinistro, Anna ;
Cavazza, Antonella ;
Ciaprini, Chiara ;
Rocchi, Giovanni ;
Bergamini, Alberto .
CYTOKINE, 2009, 45 (03) :190-197
[6]   Vitamin D status is independently associated with plasma glutathione and cysteine thiol/disulphide redox status in adults [J].
Alvarez, Jessica A. ;
Chowdhury, Ritam ;
Jones, Dean P. ;
Martin, Greg S. ;
Brigham, Kenneth L. ;
Binongo, Jose N. ;
Ziegler, Thomas R. ;
Tangpricha, Vin .
CLINICAL ENDOCRINOLOGY, 2014, 81 (03) :458-466
[7]  
American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5
[8]   Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial [J].
Anagnostou, Evdokia ;
Soorya, Latha ;
Chaplin, William ;
Bartz, Jennifer ;
Halpern, Danielle ;
Wasserman, Stacey ;
Wang, A. Ting ;
Pepa, Lauren ;
Tanel, Nadia ;
Kushki, Azadeh ;
Hollander, Eric .
MOLECULAR AUTISM, 2012, 3
[9]  
[Anonymous], COMPANION STATEMENT
[10]  
Arvidsson T.B., 1997, AUTISM, V1, P163, DOI 10.1177/1362361397012004